Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn?

Helen Alexander*, Frank O. Nestle

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: This review presents our current understanding of the pathogenesis and treatment of psoriasis with a particular focus on recent areas of research and emerging concepts. RECENT FINDINGS: Psoriasis arises in genetically predisposed individuals who have an abnormal innate and adaptive immune response to environmental factors. Recent studies have identified novel genetic, epigenetic and immunological factors that play a role in the disease pathogenesis. There is emerging evidence for the role of the skin microbiome in psoriasis. Studies have shown reduced diversity and altered composition of the skin microbiota in psoriasis. SUMMARY: Recent advances in our understanding of the complex immunopathogenesis of psoriasis have led to the identification of crucial cytokines and cell signalling pathways that are targeted by a range of immunotherapies.

Original languageEnglish
Pages (from-to)71-78
Number of pages8
JournalCurrent Opinion in Rheumatology
Volume29
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • Adaptive Immunity
  • Biomarkers/blood
  • Cytokines/immunology
  • Epigenomics
  • Gene Expression Profiling/methods
  • Genomics/methods
  • Humans
  • Immunologic Factors/therapeutic use
  • Immunotherapy/methods
  • Microbiota
  • Psoriasis/etiology
  • Skin/microbiology

Fingerprint

Dive into the research topics of 'Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn?'. Together they form a unique fingerprint.

Cite this